Codetta Bio
PrivateLast Round
VC Round
Oct 29, 2024
Total Funding Raised
$17M
Company Overview
Codetta Bio is a biotechnology company founded in 2021 that develops advanced multi-omic analysis tools for comprehensive biomarker measurement. The company's platform, known as the Concerto System, integrates digital PCR, qPCR, and immunoPCR technologies to enable simultaneous, multi-plexed analysis of DNA, RNA, and protein from a single specimen, such as a liquid biopsy. Codetta Bio aims to provide researchers and clinicians with a new standard in biomarker insights, offering high sensitivity and efficiency for applications in precision medicine, research, and diagnostic development. The company is actively raising capital and forming strategic partnerships to commercialize its technology.
Sector
Healthcare & Life Sciences
Verticals
Biotech Equipment, Precision Medicine, Biotechnology, Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales, Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Codetta Bio Comps
Public and private peers based on sector, stage, and business model.
Codetta Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Oct 29, 2024 | ||||
| Grant | Nov 8, 2022 | ||||
| Series A | Apr 7, 2022 |
Codetta Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| North Carolina Collaboratory | Grant |
| 2ndF | VC Round |
| Genoa Ventures | Series A, VC Round |
| Anzu Partners | VC Round, Series A |
| VC23 Investors | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 26, 2026
Announced new customizable Cytokine and neuroscience panels for its Concerto system.
- Feb 26, 2026
Concerto system now fully commercially available.
Codetta Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Codetta Bio's valuation, stock price, and market status.
